
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+7
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. As an organization, Karyopharm is on a mission to improve lives and defeat cancer. In its role as leaders in XPO1 inhibition, Karyopharm delivers on its mission by creating a focused pipeline that targets multiple high unmet need cancer indications, including multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma (DLBCL)
Oncology,pharmaceutical,biotech,multiplemyeloma,lymphoma,solidtumors,clinicalresearch,clinicaltrials,research,drugdiscovery,medical,and healthcare
Karyopharm therapeutics inc operates in the Pharmaceutical manufacturing industry.
Karyopharm therapeutics inc's revenue is 101m - 500m
Karyopharm therapeutics inc has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.